Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Evoke Pharma Inc as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q4 2021
- Shares held
- 2.00M
- −49.5K (−2.4%) vs. Q4 2021
- Total value
- $987.0K
- −$143.0K (−12.7%) vs. Q4 2021
- New holders
- 2
- 6 more added
- Sold out
- 5
- 6 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 15 | $2.94M |
| Q2 2025 | 10 | $603.6K |
| Q1 2025 | 10 | $678.2K |
| Q4 2024 | 8 | $965.6K |
| Q3 2024 | 12 | $994.6K |
| Q2 2024 | 16 | $1.67M |
| Q1 2024 | 15 | $1.93M |
| Q4 2023 | 11 | $71.8K |
| Q3 2023 | 11 | $92.4K |
| Q2 2023 | 11 | $97.4K |
| Q1 2023 | 12 | $131.1K |
| Q4 2022 | 12 | $161.2K |
| Q3 2022 | 11 | $117.0K |
| Q2 2022 | 13 | $228.0K |
| Q1 2022 | 22 | $987.0K |
| Q4 2021 | 25 | $1.13M |
| Q3 2021 | 23 | $5.46M |
| Q2 2021 | 22 | $6.17M |
| Q1 2021 | 25 | $7.83M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Evoke Pharma Inc; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 185 | $0 | 0.00% | +2+1.1% | Added |
| FMR LLC | 47 | $0 | 0.00% | −102−68.5% | Reduced |
| Advisor Group Holdings, Inc. | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 60 | $30 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 3,042 | $1.00K | 0.00% | +700+29.9% | Added |
| Spire Wealth Management | 5,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 6,224 | $3.00K | 0.00% | −3,382−35.2% | Reduced |
| Tower Research Capital LLC (TRC) | 10,807 | $5.00K | 0.00% | +6,650+160.0% | Added |
| Laird Norton Trust Company, LLC | 11,000 | $5.00K | 0.00% | +11,000 | New |
| Pure Financial Advisors, Inc. | 17,647 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 24,717 | $12.0K | 0.00% | +21,144+591.8% | Added |
| Renaissance Technologies LLC | 28,200 | $14.0K | 0.00% | −17,335−38.1% | Reduced |
| Wambolt & Associates, LLC | 32,000 | $15.0K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 42,793 | $21.0K | 0.00% | −12,543−22.7% | Reduced |
| Northern Trust Corp | 42,121 | $21.0K | 0.00% | 00.0% | Unchanged |
| Cornerstone Capital, Inc. | 66,000 | $33.0K | 0.00% | +66,000 | New |
| State Street Corp | 82,645 | $41.0K | 0.00% | +9,845+13.5% | Added |
| Raymond James Financial Services Advisors, Inc. | 108,545 | $54.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 177,127 | $88.0K | 0.00% | −3,204−1.8% | Reduced |
| Geode Capital Management, LLC | 222,948 | $110.0K | 0.00% | +12,846+6.1% | Added |
| Vanguard Group Inc | 1,116,673 | $553.0K | 0.00% | −7,971−0.7% | Reduced |
| Sabby Management, LLC | 0 | $0 | 0.00% | −87,925−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,592−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,775−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,828−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −48−100.0% | Sold out |